Clinical Trial Update: Randomized, Double-blind, Placebo-controlled Study in Patients With Fistulizing Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, placebo-controlled study in fistulizing Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fistulizing Crohn Disease

Snippet

Sponsor: Delenex Therapeutics AG | Conditions: Fistulizing Crohn's Disease | Phase 2 | Status: COMPLETED